Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
Clasificación en acciones #28057
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Precio por acción
$0.04020123
Capitalización bursátil
$28.83M
Cambio (1 día)
0.00%
Cambio (1 año)
-31.34%
País
AU
Comercio Microba Life Sciences Limited (MAP)

Categoría

Ganancias de Microba Life Sciences Limited (MAP)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Microba Life Sciences Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Microba Life Sciences Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US